Besides, PTPRN was reported to be overexpressed in several cancers such as glioblastoma (Xu et al., 2018; Yin et al., 2019) and hepatocellular carcinoma (Zhangyuan et al., 2018). Here, PTPRN is linked to glioblastoma.